Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?

Journal of the American Society of Cytopathology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles